Pharmabiz17 m
CStone Pharma announces inclusion of Cejemly as a first-line combination therapy for NSCLC in ESMO guideline
In combination with fluoropyrimidine- and platinum-containing chemotherapy as first-line treatment for unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) ...